| RAMP-DM (N = 1072) | Usual care (N = 1072) |  |
---|---|---|---|
 | Mean ± SD or n(%) | P-valuea | |
Demographic | |||
Age (year) | 64.3 ± 10.9 | 65.3 ± 11.7 | 0.056 |
Male | 534 (49.8%) | 534 (49.8%) | 1.000 |
Smokers | 106 (9.9%) | 90 (8.4%) | 0.231 |
Cluster information | Â | Â | 0.767 |
HKEC | 268 (25.0%) | 278 (25.9%) | Â |
KCC | 270 (25.2%) | 274 (25.6%) | Â |
KWC | 256 (23.9%) | 262 (24.4%) | Â |
NTEC | 278 (25.9%) | 258 (24.1%) | Â |
Clinical | |||
T2DM | 1064 (99.5%) | 1006 (93.8%) | <0.001 |
Duration of DM (year) | 7.9 ± 6.2 | 7.9 ± 6.6 | 0.759 |
HbA1c (%) | 7.26 ± 1.17 | 7.13 ± 1.17 | 0.033 |
TC(mmol/L) | 5.05 ± 0.96 | 4.87 ± 0.94 | <0.001 |
HDL-C (mmol/L) | 1.23 ± 0.34 | 1.23 ± 0.33 | 0.830 |
LDL-C (mmol/L) | 3.10 ± 0.80 | 2.89 ± 0.79 | <0.001 |
Triglycerides (mmol/L) | 1.63 ± 1.08 | 1.56 ± 1.00 | 0.2495 |
SBP ≤ 140 mmHg | 615 (58.7%) | 634 (69.3%) | <0.001 |
DBP ≤ 80 mmHg | 700 (66.8%) | 687 (75.1%) | <0.001 |
SBP/DBP ≤ 140/80 mmHg | 538 (58.8%) | 491 (46.9%) | <0.001 |
No(%) reaching treatment target | |||
HbA1c < 7% | 467 (50.54%) | 384 (54.9%) | 0.079 |
SBP < 130 mmHg | 365 (34.8%) | 412 (45.0%) | <0.001 |
DBP < 80 mmHg | 700 (66.8%) | 687 (75.1%) | <0.001 |
SBP/DBP < 130/80 mmHg | 323 (30.8%) | 381 (41.6%) | <0.001 |
LDL-C < 2.6 mmol/L | 154 (27.3%) | 132 (39.4%) | <0.001 |
Predicted cardiovascular risk (%) | |||
Framingham 10-year CVD riskb | 35.18 ± 20.68 | 33.32 ± 20.16 | 0.0882 |
UKPDS 10-year CHD riskc | 23.25 ± 16.29 | 22.00 ± 15.90 | 0.177 |
UKPDS 10-year stroke riskd | 14.51 ± 15.21 | 15.06 ± 15.79 | 0.6439 |